BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

794 related articles for article (PubMed ID: 16320348)

  • 1. Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus?
    To CH; Petri M
    Arthritis Rheum; 2005 Dec; 52(12):4003-10. PubMed ID: 16320348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal fluctuation of antibodies to extractable nuclear antigens in systemic lupus erythematosus.
    Faria AC; Barcellos KS; Andrade LE
    J Rheumatol; 2005 Jul; 32(7):1267-72. PubMed ID: 15996063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cluster analysis of autoantibodies in 852 patients with systemic lupus erythematosus from a single center.
    Artim-Esen B; Çene E; Şahinkaya Y; Ertan S; Pehlivan Ö; Kamali S; Gül A; Öcal L; Aral O; Inanç M
    J Rheumatol; 2014 Jul; 41(7):1304-10. PubMed ID: 24833757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival impact of autoantibodies in systemic lupus erythematosus.
    Gulko PS; Reveille JD; Koopman WJ; Burgard SL; Bartolucci AA; Alarcón GS
    J Rheumatol; 1994 Feb; 21(2):224-8. PubMed ID: 8182629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of autoantibodies before the clinical onset of systemic lupus erythematosus.
    Arbuckle MR; McClain MT; Rubertone MV; Scofield RH; Dennis GJ; James JA; Harley JB
    N Engl J Med; 2003 Oct; 349(16):1526-33. PubMed ID: 14561795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
    Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
    Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic value of anti-RNP/Sm and anti-Ro/La antibodies in lupus nephropathy].
    López-Longo FJ; López-Gómez JM; Jofre Ibáñez R; Escalona M; Rodríguez-Mahou M
    Rev Clin Esp; 1992 Nov; 191(7):354-9. PubMed ID: 1475460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and prognostic value of autoantibodies in puerto Ricans with systemic lupus erythematosus.
    Vilá LM; Molina MJ; Mayor AM; Peredo RA; Santaella ML; Vilá S
    Lupus; 2006; 15(12):892-8. PubMed ID: 17211998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical autoantibodies in patients with primary Sjögren syndrome: clinical characteristics and follow-up of 82 cases.
    Ramos-Casals M; Nardi N; Brito-Zerón P; Aguiló S; Gil V; Delgado G; Bové A; Font J
    Semin Arthritis Rheum; 2006 Apr; 35(5):312-21. PubMed ID: 16616154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical, serologic, and genetic profiles of patients with associated Sjögren's syndrome and systemic lupus erythematosus.
    Szanto A; Szodoray P; Kiss E; Kapitany A; Szegedi G; Zeher M
    Hum Immunol; 2006 Nov; 67(11):924-30. PubMed ID: 17145372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of autoantibodies using multiplex methodology in patients with systemic lupus erythematosus.
    Hanly JG; Thompson K; McCurdy G; Fougere L; Theriault C; Wilton K
    J Immunol Methods; 2010 Jan; 352(1-2):147-52. PubMed ID: 19836394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Autoantibodies in systemic lupus erythematosus: spectrum and clinical associations].
    Haddouk S; Ben Ayed M; Baklouti S; Hachicha J; Bahloul Z; Masmoudi H
    Pathol Biol (Paris); 2005 Jul; 53(6):311-7. PubMed ID: 16004941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
    Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC
    Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-RO anti-LA anti-RNP antibodies and eletrocardiogram's PR interval in adult patients with systemic lupus erythematosus.
    Costa M; Gameiro Silva MB; Silva JA; Skare TL
    Acta Reumatol Port; 2008; 33(2):173-6. PubMed ID: 18604183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of DNase IV polymorphisms with autoantibodies in patients with systemic lupus erythematosus.
    Kim I; Hur NW; Shin HD; Park BL; Cheong HS; Bae SC
    Rheumatology (Oxford); 2008 Jul; 47(7):996-9. PubMed ID: 18417526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-BB'-Sm antibodies, anticardiolipin antibodies, and thrombosis in systemic lupus erythematosus.
    López-Longo FJ; Monteagudo I; González CM; Moreno AC; Rodríguez Mahou M; Grau R; Carreño L
    J Rheumatol; 1998 Sep; 25(9):1743-9. PubMed ID: 9733455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rheumatological manifestations, organ damage and autoimmunity in hereditary C2 deficiency.
    Jönsson G; Sjöholm AG; Truedsson L; Bengtsson AA; Braconier JH; Sturfelt G
    Rheumatology (Oxford); 2007 Jul; 46(7):1133-9. PubMed ID: 17478473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies to the 20-kDa ribosomal proteins: identification, characterization, and new aspects on prevalence in systemic Lupus erythematosus.
    Anderson CJ; Neas BR; Uchiumi T; Stafford HA
    Clin Immunol; 2001 Feb; 98(2):249-57. PubMed ID: 11161982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early clinical manifestations, disease activity and damage of systemic lupus erythematosus among two distinct US Hispanic subpopulations.
    Vilá LM; Alarcón GS; McGwin G; Friedman AW; Baethge BA; Bastian HM; Fessler BJ; Reveille JD;
    Rheumatology (Oxford); 2004 Mar; 43(3):358-63. PubMed ID: 14623949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.